Schoedel Kerri A, Hoffmann Ewa B, Rao Yushu, Sellers Edward M, Tyndale Rachel F
Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada.
Pharmacogenetics. 2004 Sep;14(9):615-26. doi: 10.1097/00008571-200409000-00006.
Genetically variable CYP2A6 is the primary enzyme that inactivates nicotine to cotinine. Our objective was to investigate allele frequencies among five ethnic groups and to investigate the relationship between genetically slow nicotine metabolic inactivation and smoking status, cigarette consumption, age of first smoking and duration of smoking. Chinese, Japanese, Canadian Native Indian, African-North American and Caucasian DNA samples were assessed for CYP2A6 allelic frequencies (CYP2A61B-12,1x2). Adult Caucasian non-smokers (n = 224) (1-99 cigarettes/lifetime) and smokers (n = 375) (> or = 100 cigarettes/lifetime) were assessed for demographics, tobacco/drug use history and DSM-IV dependence and genotyped for CYP2A6 alleles associated with decreased nicotine metabolism (CYP2A62, CYP2A64, CYP2A69, CYP2A6*12). CYP2A6 allele frequencies varied substantially among the ethnic groups. The proportion of Caucasian slow nicotine inactivators was significantly lower in current, DSM-IV dependent smokers compared to non-smokers [7.0% and 12.5%, respectively, P = 0.03, odds ratio (OR) = 0.52; 95% confidence interval (CI) 0.29-0.95]; non-dependent smokers showed similar results. Daily cigarette consumption (cigarettes/day) was significantly (P = 0.003) lower for slow (21.3; 95% CI 17.4-25.2) compared to normal inactivators (28.2; 95% CI 26.4-29.9); this was observed only in DSM-IV dependent smokers. Slow inactivators had a significantly (P = 0.03) lower age of first smoking compared to normal inactivators (13.0 years of age; 95% CI 12.1-14.0 versus 14.2; 95% CI 13.8-14.6), and a trend towards smoking for a shorter duration. This study demonstrates that slow nicotine inactivators are less likely to be adult smokers (dependent or non-dependent). Slow inactivators also smoked fewer cigarettes per day and had an earlier age of first smoking (only dependent smokers).
基因可变的CYP2A6是将尼古丁失活为可替宁的主要酶。我们的目的是调查五个种族群体中的等位基因频率,并研究尼古丁代谢失活缓慢的基因与吸烟状况、香烟消费量、首次吸烟年龄和吸烟持续时间之间的关系。对中国、日本、加拿大原住民印第安人、北美非洲人和高加索人的DNA样本进行了CYP2A6等位基因频率(CYP2A61B-12,1x2)评估。对成年高加索非吸烟者(n = 224)(终生吸烟1-99支)和吸烟者(n = 375)(终生吸烟≥100支)进行了人口统计学、烟草/药物使用史和DSM-IV依赖性评估,并对与尼古丁代谢降低相关的CYP2A6等位基因(CYP2A62、CYP2A64、CYP2A69、CYP2A6*12)进行基因分型。CYP2A6等位基因频率在不同种族群体中差异很大。与非吸烟者相比,目前依赖DSM-IV的吸烟者中高加索尼古丁失活缓慢者的比例显著更低[分别为7.0%和12.5%,P = 0.03,优势比(OR) = 0.52;95%置信区间(CI)0.29 - 0.95];非依赖吸烟者也有类似结果。与正常失活者相比,失活缓慢者的每日香烟消费量(支/天)显著更低(P = 0.003)[失活缓慢者为21.3;95% CI 17.4 - 25.2,正常失活者为28.2;95% CI 26.4 - 29.9];这仅在依赖DSM-IV的吸烟者中观察到。与正常失活者相比,失活缓慢者的首次吸烟年龄显著更低(P = 0.03)(失活缓慢者为13.0岁;95% CI 12.1 - 14.0,正常失活者为14.2岁;95% CI 13.8 - 14.6),且有吸烟持续时间更短的趋势。本研究表明,尼古丁失活缓慢者不太可能成为成年吸烟者(依赖或不依赖)。失活缓慢者每天吸烟也更少,且首次吸烟年龄更早(仅依赖吸烟者)。